Instruction for use: Lanotan

Dosage Form: eye drops

Active substance: Latanoprost*

ATX

S01EE01 Latanoprost

Pharmacotherapeutic groups:

Antiglaucoma means - prostaglandin F2α analogue synthetic [Prostaglandins, thromboxanes, leukotrienes and their antagonists]

Antiglaucoma means - prostaglandin F2α analogue synthetic [Ophthalmic agents]

The nosological classification (ICD-10)

H40.0 Glaucoma suspected: Severe elevation of intraocular pressure; Hypertension of the eye; Eye hypertension; Measurement of intraocular pressure; Ophthalmic Hypertension; Increased IOP; Increased intraocular pressure; Increased intraocular pressure in infectious diseases of the eyes; Increased intraocular pressure; Increased ophthalmotonus; Spontaneous blockade of the angle of the opposite eye; Narrow chamber angle; Iatrogenic blockade of the angle of the opposite eye

H40.1 Primary open angle glaucoma: Open-angle glaucoma; Open angle glaucoma; Primary glaucoma; Pseudoexfoliation glaucoma; Increased IOP

H40.2 Primary angle-closure glaucoma: Closed-angle glaucoma; Glaucoma with a narrow angle of the anterior chamber; Closed-angle glaucoma; Sharp angle-closure glaucoma; Acute attack of angle-closure glaucoma; Increased intraocular pressure with angle-closure glaucoma; Chronic occlusive glaucoma

H40.8 Other glaucoma: Juvenile glaucoma; Chronic open angle glaucoma; Glaucoma-cyclical crisis; Posner-Schlossmann syndrome

Composition

Eye drops 1 ml

active substance:

Latanoprost in terms of 100% dry matter 0.05 mg

Auxiliary substances: benzalkonium chloride in terms of 100% substance - 0.2 mg; Sodium chloride - 4 mg; Sodium dihydrogen phosphate monohydrate - 4.5 mg; Sodium hydrophosphate anhydrous - 4.7 mg; Water for injection - up to 1 ml

Pharmacology

Mode of action - antiglaucoma, lowering the intraocular pressure.

Dosing and Administration

Conjunctival.

The recommended dose for adults (including the elderly) is 1 drop in each affected eye once a day. The optimal effect is achieved with the administration of Lanotan in the evening. Do not use Lanotan more than once a day, because It is shown that application more often than once a day, reduces the effect of reducing IOP.

If a dose was missed, then further treatment should be continued and the next dose administered as usual.

After instillation of Lanolot preparation, as well as any other eye drops, it is recommended to compress the tear sack for 1 minute in the medial angle of the eye (lacrimal occlusion). This action should be performed immediately after the administration of each drop.

Before dropping eye drops contact lenses should be removed, and they can be put on only 15 minutes after instillation. If more than one local ophthalmic preparation is used, the medication should be given at intervals of not less than 5 minutes.

Use in children: eye drops Lanolot can be used in children with the same dosing regimen as in adults. Data on the use in preterm infants (gestational age less than 36 weeks) are absent. Data on use in the age group under 1 year are inadequate (4 patients).

Release form

Eye drops, 0.05 mg / ml. In PE bottles, ukuporennyh droppers and caps PE screw with autopsy control, 2.5 ml. Each label has a self-adhesive label. 1 fl. In a pack of cardboard.

Terms of leave from pharmacies

On prescription.

Storage conditions of Lanotan

In the dark place at a temperature of 2-8 ° C.

Keep out of the reach of children.

Shelf life of Lanotan

2 years. After opening the bottle - 28 days.

Do not use beyond the expiration date printed on the package.